I believe the success of our innovative use of arsenic trioxide (ATO) to treat APL has been our biggest contribution to the world. It illustrates our pioneering spirit as one of the first four ...

Extensive clinical studies of oral-ATO have demonstrated its high efficacy and safety in curing APL patients, with an overall survival (OS) rate exceeding 97%, along with a significant reduction ...

In 2003, Pankaj Malhotra, Head, Department of Clinical Hematology, PGIMER, introduced arsenic trioxide (ATO) and all-trans ...

NATO members Poland, Lithuania, Latvia and Estonia said Tuesday they are abandoning the 1997 Ottawa convention treaty ...

The introduction of all-trans retinoic acid in 1985 combined with anthracycline-based chemotherapy has revolutionized the prognosis of acute promyelocytic leukemia (APL) with current complete ...